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TheWiskott–Aldrich syndrome (WAS) is due to mutations of theWAS gene encoding for the
cytoskeletal WAS protein, leading to abnormal downstream signaling from theT cell and B
cell antigen receptors (TCR and BCR).We hypothesized that the impaired signaling through
theTCR and BCR in WAS would subsequently lead to aberrations in the immune repertoire
of WAS patients. Using next generation sequencing (NGS), the T cell receptor β and B cell
immunoglobulin heavy chain (IGH) repertoires of eight patients with WAS and six controls
were sequenced. Clonal expansions were identified within memory CD4+ cells as well as
in total, naïve and memory CD8+ cells from WAS patients. In the B cell compartment, WAS
patient IGH repertoires were also clonally expanded and showed skewed usage of IGHV
and IGHJ genes, and increased usage of IGHG constant genes, compared with controls.
To our knowledge, this is the first study that demonstrates significant abnormalities of the
immune repertoire in WAS patients using NGS.
Keywords: Wiskott–Aldrich syndrome, immune repertoire, next generation sequencing, deep sequencing, B cell
receptor,T cell receptor, somatic hypermutation, clonotypic expansion
INTRODUCTION
The Wiskott–Aldrich syndrome (WAS) is an X-linked disease char-
acterized by the triad of eczema, microthrombocytopenia, and
immunodeficiency (1, 2). Patients are also predisposed to autoim-
munity and malignancy, resulting in poor clinical outcome overall
(3, 4). The WAS gene encodes for the WAS protein (WASp) (5),
which is expressed solely in hematopoietic cells, and is recruited to
the inner cell membrane in response to activating signals, includ-
ing engagement of the T and B cell antigen receptors (TCR and
BCR) (6, 7). Upon activation, WASp recruits the Arp2/3 complex,
triggering actin polymerization (8).
Deficiency of WASp is associated with significant immune
abnormalities that affect all leukocytes (9). In particular, WAS
patients manifest progressive T cell lymphopenia (10) and
impaired formation of the immune synapse, defective IL-2 secre-
tion, and reduced proliferation in response to TCR ligation
(11, 12). The B cell compartment is also affected in WAS.
Increased autoantibody production has been demonstrated in
WASp-deficient patients and mice, and studies in mice lacking
WASp solely in B lymphocytes have showed that this immune
dysregulation reflects B cell intrinsic mechanisms, with increased
hyper-responsiveness of WASp-deficient B cells to both BCR and
toll-like receptor signaling (13, 14). WASp is also an important
regulator of marginal zone (MZ) B cell maturation and posi-
tioning (15). It has been also reported that patients with WAS
have an increased proportion of circulating CD19+ CD21low
CD38low B cells (16, 17), which have been characterized as
autoreactive-prone B cells (18). Finally, WAS patients have an
increased number of peripheral transitional B cells and a con-
comitant decrease in immature B cells in the bone marrow
(16). These abnormalities are probably secondary to decreased
responsiveness to the chemotactic factor CXCL12, which sig-
nals through CXCR4 to retain immature B cells in the bone
marrow.
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T cell receptor- and BCR-mediated signaling plays a critical
role in determining T and B cell fate during development and
antigen-specific responses, and therefore, contributes to shaping
the peripheral T and B cell repertoire. The diversity and complex-
ity of the immune repertoire may in turn affect robustness of the
immune response and disease outcome (19). Only limited infor-
mation is available on TCR and BCR repertoire diversity and com-
position in WAS. Using complementarity determining region 3
(CDR3) spectratyping,Wada et al. demonstrated reduced diversity
of the T cell receptor β (TRB) repertoire in WAS patients>15 years
of age (20). More recently, limited diversity of the TRB repertoire
was demonstrated with the same technique also in young WAS
patients, and this abnormality was corrected by gene therapy (21).
Finally, two groups have recently reported skewed usage of IGHV
genes belonging to the VH3 and VH4 families in circulating B cells
from patients with WAS, and reduced rate of somatic hypermu-
tation (SHM) among Cγ- and Cα-containing immunoglobulin
transcripts (16, 17). However, studies of T and B cell receptor
repertoire diversity in WAS have been conducted using tech-
niques (CDR3 spectratyping, targeted cloning, and sequencing)
that permit only a descriptive assessment, or that sample only a
limited number of sequences. Next generation sequencing (NGS)
involves the use of high throughput sequencing technology to
simultaneously amplify and analyze thousands of DNA or RNA
sequences [reviewed in Ref. (22–25)]. Using this approach, sin-
gle TCR and BCR rearranged genomic products or transcripts
contained in a given sample can be amplified and individually
sequenced. This permits robust analysis of repertoire diversity,
and to assess the possible presence of clonotypic expansions; V, D,
and J segment usage patterns; distribution and amino acid com-
position of CDR3 regions; sharing of CDR3 clonotypes between
cell compartments; and SHM frequency. Here, we report for the
first time on the use of NGS to analyze the expressed TRB and
IGH repertoire of circulating T and B lymphocyte subsets isolated
from patients with WAS and healthy controls. Our results demon-
strate that patients with WAS present significant restriction of
the TRB repertoire as well as abnormal distribution of the CDR3
length and skewed usage of V and J gene elements both at TRB
and at the IGH loci. These abnormalities are present already at
young age and are especially prominent within CD8+ T lympho-
cytes, possibly reflecting recurrent and/or chronic infections or
the emergence of somatic revertant clones. Restriction of reper-
toire diversity may further contribute to the immunodeficiency
of WAS.
MATERIALS AND METHODS
STUDY SUBJECTS
Approval for the study was obtained from the Boston Children’s
Hospital (BCH) institutional review board prior to initiation.
Informed consent (and informed assent where appropriate) was
granted by all study subjects and/or parents/guardians at the
time of enrollment. Peripheral blood samples from patients with
WAS (W1–W8) and healthy controls (C1–C6) were obtained by
venipuncture either at BCH or at the collaborating institutions.
Samples shipped from collaborators were processed within 4 days
of the sample being drawn.
SAMPLE PREPARATION
Isolating cell sub-populations
Peripheral blood mononuclear cells (PBMCs) were isolated from
peripheral blood using Ficoll Paque Plus (GE Healthcare, Boston,
MA, USA) gradient cell separation according to manufacturer’s
instructions. Red blood cells were lysed using a 1× dilution of BD
Pharm lyse (BD Biosciences) in sterile water and incubating the
cells for 5–10 min. For total CD4, CD8, and B cell samples, iso-
lated PBMCs were labeled sequentially with anti-human CD4 and
CD8 magnetic beads (Miltenyi Biotec, San Diego, CA, USA) and
respective fractions were obtained by positive magnetic selection
while B cell-enriched fraction was obtained by negative selec-
tion of CD4+ and CD8+ PBMCs. For CD4 and CD8 naïve and
memory populations, isolated PBMCs were labeled with mouse
anti-human fluorescent antibodies: anti-CD3 PE/Cy7, anti-CD4
PE, anti-CD8 APC, anti-CD45RA FITC, and anti-CCR7 Pacific
Blue (eBiosciences, San Diego, CA, USA). Cells were stained for
30 min and then washed and sorted on a BD FACS Aria II cell
sorter. Naïve CD4+ and CD8+ T cells were sorted based on the
CD45RA+ CCR7+ phenotype. With this sorting strategy, the naïve
T cell compartment did not include CD45RA+ CCR7− cells that
correspond to the exhausted effector memory T cell (TEMRA),
which is often expanded in patients with WAS (Table 1). Cell
purity was checked after sorting and was consistently >92%.
Reverse transcription PCR and sequencing
Sorted cells were placed in Trizol (Ambion, Inc/Life Technologies,
Grand Island, NY, USA) and mRNA was extracted according to the
manufacturer’s instructions. mRNA samples were then subjected
to reverse transcription PCR (RT-PCR) using a Qiagen OneStep
RT-PCR kit (Qiagen Inc., Valencia, CA, USA) and iRepertoire®
human T cell beta receptor (HTBR) primers (iRepertoire Inc.,
Huntsville, AL, USA) for T cell samples, or human immunoglob-
ulin heavy chain (HIGH) primers for B cell samples, under the
reaction conditions specified by iRepertoire®. Each primer con-
tained a barcode that was integrated into the PCR, allowing donor
identification. A second PCR was then carried out using a Qiagen
Multiplex PCR kit and the iRepertoire® 454 Lib-A primers, again
under conditions specified by iRepertoire®. The samples were run
on a 2% agarose gel, and then the DNA in the 350–500 bp range
was excised and extracted from the gel using a Qiagen Gel Extrac-
tion kit, according to manufacturer’s instructions. The samples
were then gel-purified second time in order to further eliminate
primers and non-specific amplification from the samples. Finally,
the DNA content of the samples was assessed using the Flash Gel
System (Lonza, Hopkinton, MA, USA) and PicoGreen (Invitro-
gen, Inc/Life Technologies, Grand Island, NY, USA) quantification
system to determine qualitative and quantitative concentration of
the PCR products. Pooled sample libraries were then sequenced
using the GS Junior 454 platform (Roche, Mannheim, Germany).
ANALYSIS OF SEQUENCING DATA
iRepertoire® provided raw data on V, D, and J segment usage for
T and B cell samples and C-region usage for B cell samples. They
also provided filtered DNA sequences utilized for additional analy-
ses. Information on CDR3 length was obtained from these filtered
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Table 1 | Patient characteristics.
ID W1 W2 W3 W4 W5 W6 W7 W8
Age 54 years 14 months 3 years 10 months 23 months 10 years 11 months 19 months
Infections Pneumonia, otitis PCP pneumonia EBV, CMV, RSV,
HSV stomatitis
Orchitis Ocular HSV Otitis, bronchitis,
pneumonia
Cellulitis Febrile illnesses
Mutation IVS6+5,G>A c. 454 C>T
(p.Q152X)
c.35delAA
(p.G12fsX)
c.8997_9001 dup
TACTC (p.110fsX13)
c.1154delG
(p.G378AX84)
IVS8+1,G>A c.1116 del T IVS3−2,A>G
WASp expression CD8+ T cells
(revertant)
None CD8+ T, NK cells
(all revertants)
None None CD4+, CD8+ T
cells (revertants)
None Reduced
CD3+ (cells/µL) 705 (1000–2600) 1803 (1900–6200) 1766 (1400–6200) 1054 (1900–6200) 1522 (1900–6200) 2986 (1000–2600) 1703 (1900–6200) 104 (1900–6200)
CD4+ (cells/µL) 611 (530–1500) 1533 (1300–3400) 890 (700–2200) 897 (1400–4300) 152 (1300–3400) 1078 (530–1500) 1377 (1400–4300) 1142 (1300–3400)
Naïve CD4+ (%) 36 (21–61.4) 59.9 (66.3–89.4) 70.8 (65.2–84.8) 74.5 (76.7–91.4) ND 11.6 (57.4–84.9) 74 (76.7–91.4) 67.7 (66.3–89.4)
Effector mem. CD4+ (%) 30 (7.6–25.1) 16.8 (1.2–9.4) 12.9 (2.9–9.8) ND ND 76.2 (3.3–15.2) 9.1 (1.1–5.3) 11.7 (1.3–9.4)
Central mem. CD4+ (%) 32.1 (26.8–62.1) 21.5 (9.2–22.4) 13.9 (10.5–23.2) ND ND 9.3 (11.3–26.7) 15.9 (6.7–15.6) 18.7 (9.2–22.4)
CD8+ (cells/µL) 92 (330–1100) 235 (620–2000) 660 (490–1300) 94 (500–1700) 1309 (620–2000) 1669 (330–1100) 250 (500–1700) 277 (620–2000)
Naïve CD8+ (%) 9.7 (11.4–66.5) 53.6 (57.8–82.9) 14.1 (39–89) ND ND 1.9 (28.4–80.6) 59.3 (62.1–94) 38.1 (57.8–82.9)
Effector mem. CD8+ (%) 45.4 (16.8–54.6) 24.7 (5.1–25.1) 26.8 (3.4–28.2) ND ND 76.7 (6.2–29.3) 20.7 (1.3–19.5) 37.7 (5.1–25.1)
Central mem. CD8+ (%) 12.6 (3.7–23.2) 1.8 (1.7–8.5) 0.6 (0.9–5.7) ND ND 0.8 (1–4.5) 2.6 (0.9–5.6) 1.5 (1.7–8.5)
TEMRA (%) 32.3 (5.6–43.9) 19.9 (6.4–20.8) 58.5 (4.8–30) ND ND 20.7 (9.1–49.1) 17.5 (1.5–22.7) 22.7 (6.4–20.8)
CD19 (cells/µL) 174 (110–570) 980 (60–2600) 282 (390–1400) 1265 (610–2600) ND 400 (270–860) 1285 (610–2600) 497 (610–2600)
CD38hi CD21lo (%) 19 (2.2–13.3) 13.6 (10.3–30.4) 12.5 (7.4–23.7) ND ND ND 19 (9.4–27) 9.6 (10.3–30.4)
CD38lo CD21+ (%) 60 69 44.2 ND ND 66.4 60.5 71.6
IgD+ CD27+ (%) 0.4 (7–23.8) 4.4 (3–10.7) 1.2 (2.7–19.8) ND ND 5.2 (5.2–20.4) 2.7 (3–10.7) 1.2 (2.7–19,8)
IgD− CD27+ (%) 7 (8.3–27.8) 4.4 (1.4–11.9) 4.6 (3.3–7.4) ND ND 11.3 (10.9–30.4) 5.7 (1.4–11.9) 3.4 (3.9–13.6)
CD38hi CD24lo (%) 4.4 (0.1–2.4) 2.2 (0.1–12.6) 2.4 (0.2–4.4) ND ND ND 2.1(0.2–3.5) 1.2 (4.1–13.9)
CD21lo CD38lo (%) 6.8 (1.1–10.7) 5.3 (1.6–7.6) 29.9 (2.3–9.3) ND ND ND 8 (0.9–5.4) 10.1 (1.6–7.6)
IgG (mg/dL) 968 (639–1344) 410 (400–1300) 864* (600–1500) 924* (300–1500) ND 1048* (630–1344) 898* (300–1500) 1292* (400–1300)
IgA (mg/dL) 763 (70–312) 59 (20–230) 128 (50–150) 71 (16–100) ND 511 (70–312) 82 (16–100) 496 (20–230)
IgM (mg/dL) 15 (34–210) 13 (30–120) <5 (22–100) 33(25–115) ND 21 (34–210) 59 (25–115) <5 (30–120)
IgE (kU/L) 238 (<200) 95 (<30) 1914 (<200) 128 (<30) ND 5769 (<200) 370 (<30) 170 (<30)
Clinical data for 8 WAS patients (W1–W8). ND, study not done; IVIG, intravenous immunoglobulins. B cell subsets were defined as follows: CD19+ CD38hi CD21lo, transitional B cells; CD19+ CD38lo CD21+, naïve B
cells; CD19+ IgD+ CD27+, unswitched memory B cells; CD19+ IgD− CD27+, switched memory B cells; CD19+ CD38hi CD24lo, plasmablasts.
*On IVIG at the time of assessment.
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FIGURE 1 | Clonal expansions and diversity of the CD4+ and CD8+ TRB
repertoire. (A)The relative frequency of the 100 most abundant clones is
displayed as a proportion of the total sequences for both CD4+ (left panel) and
CD8+ (right panel) populations. The black line indicates the mean of the
sample. (B)The degree of clonal expansion for CD4+ and CD8+ populations is
displayed by plotting the cumulative percentage of unique clones (x ) vs. the
cumulative percentage of total sequences (y ). A slope of one would indicate
an even distribution of clonotypes. The dotted gray vertical line indicates 90%
of cumulative unique sequences, with sequences to the right of the line
corresponding to the top 10% most abundant unique clonotypes. (C)The
diversity of each patient’s repertoire was determined by dividing the number
of unique sequences over the total sequences for CD4+ and CD8+
populations. Bars represent mean and SE. In all panels, the same color is
used to identify individual control subjects and patients.
sequence files. Unique filtered DNA sequences were also multiplied
to reflect the number of copies present for each sequence in a popu-
lation using Microsoft excel. CSV output files from Excel were then
converted into FASTA format using Geneious software. FASTA files
were uploaded to the ImMunoGeneTics (IGMT) database and the
IMGT/high V-Quest web-based analysis tool (26), which provided
sequence output files. The IGMT mutation analysis files were used
to calculate the number of mutations at each amino acid residue
for the various CDR and framework regions (FR). The mutation
index was calculated by dividing the total number of mutations in
each FR or CDR region, by the total nucleotide length of the FR or
CDR region analyzed, and finally dividing that by the total num-
ber of unique sequences obtained for each population analyzed.
IGMT output files were uploaded into IgAT analysis tool (27) to
allow analysis of biodiversity. Finally, rarefaction curves for each
sample were generating using PAST (28).
STATISTICAL ANALYSES
As outcome variables were ordinal in nature and a normal distri-
bution could not be assumed for any of the dependent variables,
the Mann–Whitney test was used to assess for differences between
controls and WAS patients. Analysis was performed using PRISM
version 6 (Graph Pad).
RESULTS
CLINICAL AND LABORATORY FEATURES
Eight WAS patients (age range: 10 months to 54 years; median:
21 months) and 6 healthy controls (age range: 9 months to 5 years;
median 4 years) were included in the study. None of the patients
had received hematopoietic cell transplantation (HCT) or gene
therapy at the time of the study. The clinical, immunological, and
molecular features of WAS patients are reported in Table 1. A his-
tory of recurrent infections was documented in seven of the eight
WAS patients, and one of them (W3) had chronic viral infec-
tions. None of the patients had significant autoimmunity. WASp
expression was analyzed in all patients (data not shown). Four
patients lacked WASp expression in all blood lineages (W2, W4,
W5, and W7); one patient (W8) had residual, but reduced, pro-
tein expression. Three patients (W1, W3, and W6) had somatic
reversions allowing WASp expression in CD8+ T cells only (W1),
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FIGURE 2 |TRBV gene usage is skewed in the CD8+ population
ofWAS patients. The frequency of usage of individual TRBV genes
among unique TRB sequences is displayed for the CD4+ (A) or
CD8+ (B) cells. The blue line indicates the average frequency of the
two control subjects, and the error bars indicate the SD of the
frequency of the controls. p Values were calculated using
Mann–Whitney test between controls and WAS for each V
segment. *p<0.05.
CD8+ and NK lymphocytes (W3), or in CD4+ and CD8+ cells
(W6). Immunological abnormalities detected in patients included
a variable degree of T cell lymphopenia, accumulation of effector
memory and of CD8+ TEMRA cells, a low number of unswitched
memory B cells, and an increased proportion of CD19+ CD21low
CD38low B cells (Table 1). Immunoglobulin serum levels were
tested in seven patients; low IgM were observed in five patients,
and increased IgA in three. Finally, all seven patients tested had
elevated serum IgE (Table 1).
SEQUENCING OUTPUT AND QUALITY ANALYSIS
The mean number of reads obtained for all samples was 7,080
(median: 4,631; range 114–31,731). No reads were obtained for
CD4+ cells from patients W4 and W5, due to an error in sample
processing; these samples were therefore excluded from all analy-
ses. The richness of each sample’s data was determined by rarefac-
tion curves, which measure increase of diversity along the depth
of sequencing. Rarefaction curves plateau as the vast majority of
species present in a population have been sampled. Rarefaction
curves indicated thorough capturing of unique TRB sequences
for most of the T cell subsets analyzed (data not shown). Similar
results were also obtained for IGH repertoire (data not shown).
ANALYSIS OF THE TRB REPERTOIRE DEMONSTRATES CLONOTYPIC
EXPANSIONS AND SKEWED USAGE OF V AND J SEGMENTS IN CD8+
LYMPHOCYTES FROM PATIENTS WITH WAS
To investigate whether CD4+ and CD8+ cells from WAS patients
contained expanded clonotypes, the frequency of the top 100
most abundant unique clonotypes was expressed as a percentage
of the total number of sequences obtained. Clonotypic expan-
sions were identified among CD4+ lymphocytes from patients
W2 and W3 and among CD8+ cells from patients W1, W2, W3,
and W5 (Figure 1A). To investigate evenness of clonotype size
distribution, we plotted the cumulative percentage of total TRB
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FIGURE 3 | Complementarity determining region 3 length
distribution of unique and total sequences for CD4+ and CD8+
TRB repertoire. Distribution of CDR3 nucleotide length frequencies
of CD4+ (A) and CD8+ (B) populations for both total and unique
clones for each WAS patient compared to control subjects C1 and
C2 (shown as curves). A double bar indicates the value of the bar
has exceeded the axis limit, and the maximum value is indicated
within brackets.
amino acid repertoire vs. the cumulative percentage of unique
TRB amino acid clonotypes ordered by increasing clonotype size.
In this representation, an even clonotype size distribution (i.e.,
all clonotypes being of the same size) would be represented by
the bisector line, and the extent of deviation from the bisector
would indicate the unevenness of the distribution. As shown in
Figure 1B, clonotypic expansions were demonstrated for CD4+
cells from patient W1, and for CD8+ cells from patients W1, W2,
W3, and W5. In particular, the top 10% most abundant unique
clones accounted for <20% of the CD4+ total sequences and
<30% of the CD8+ total sequences in control subjects. In con-
trast, the top 10% most abundant unique sequences accounted
for as many as 50% of the CD4+ total sequences in patient W1
and more than 90% of the CD8+ total sequences in patients
W3 and W5.
To measure diversity, the number of unique clones in each
sample was divided by the total number of sequences obtained.
A diversity index of 1 indicates that each unique clone is repre-
sented only one time, whereas diversity approaching 0 indicates
that only a few clones were redundantly expressed. As shown in
Figure 1C, the diversity of WAS CD4+ cells was variable, but over-
all similar to that of CD4+ cells from healthy controls. In contrast,
CD8+ cells from WAS patients had markedly reduced diversity,
although statistical significance was not reached, due to the limited
sample size.
Analysis of the frequency of usage of individual TRBV genes
among unique CD4+ clonotypes revealed a similar pattern in WAS
patients and controls (Figure 2A). In contrast, for CD8+ cells,
there was a wider distribution in the frequency of TRBV segment
usage in unique CD8+ clonotypes from WAS patients compared
with controls (Figure 2B). In particular, TRBV2 was less fre-
quently expressed in CD8+ cells from WAS patients than controls
(p= 0.05). A few other genes (TRBV29-1, TRBV9, TRBV10-3, and
TRBV12-3) tended to be under- or hyper-represented in CD8+
T cells from patients vs. controls, but the trends did not reach
significance. It is important to note that V gene results are dis-
played on a logarithmic graph, so while values were obtained for
all WAS patients for each gene, genes with expression approaching
0 will fall below the lower limit of the y-axis on these graphs, and
therefore, not be displayed.
Computational analysis permits to construct “virtual spec-
tratyping” to indicate the relative frequency with which sequences
of CDR3 region of the TRB (CDR-B3) of various lengths are rep-
resented among both the total and the unique TRB sequences.
A similar distribution of the CDR-B3 length was observed for
both unique and total sequences obtained from CD4+ cells from
patients and controls (Figure 3A). In contrast, significant devi-
ation from the bell-shaped curve was observed for total CDR-
B3 sequences from CD8+ cells from patients W1, W3, and W5
(Figure 3B), and aberrant kurtosis was detected in patient W2
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FIGURE 4 | Complementarity determining region 3 length analysis ofTRBV6-5 expressing clonotypes subgroups. Length distribution of the CDR3 region
of unique and total clones containing TRBV6-5 in both CD4 and CD8 populations from WAS patients (bars) and controls (blue line).
(Figure 3B). Furthermore, an abnormal distribution of CDR-
B3 length was also detected for unique sequences obtained from
CD8+ cells from patients W3 and W5. Overall, these data con-
firm that skewing of the TRB repertoire is especially prominent
in CD8+ cells from patients with WAS. Discrepancy in virtual
spectratyping between unique and total sequences obtained from
CD8+ cells from patients W1 and W2 is consistent with the uneven
distribution of clonotype sizes in these patients (Figure 1B).
However, abnormalities of virtual spectratyping among unique
sequences from CD8+ lymphocytes from patients W3 and W5 is
indicative of markedly reduced diversity of the TRB repertoire, as
also shown in Figure 1C.
To further confirm that virtual spectratyping may identify
specific abnormalities of the immune repertoire, we analyzed dis-
tribution of CDR-B3 length among unique and total sequences
containing TRBV6-5, a gene that was abundantly used both in
patients and controls (Figure 2). As shown in Figure 4, frequency
of CDR-B3 transcripts of various lengths followed a bell-shaped
pattern among both unique and total sequences from CD4+ and
CD8+ lymphocytes from healthy controls (blue line). A similar
pattern was also observed for unique CD4+ and CD8+ clonotypes
from patient W1. In contrast, an aberrant distribution of CDR-
B3 length was detected among total sequences from CD4+ and
CD8+ lymphocytes of the same patient, consistent with clonotypic
expansions, previously shown in Figure 1B. On the other hand,
skewing of CDR-B3 distribution was observed among both unique
and total CD8+ sequences from patients W3 and W5, indica-
tive of severe repertoire restriction. Indeed, only three unique
TRBV6-5-containing sequences were detected in CD8+ lympho-
cytes from patient W3, and two such sequences in patient W5.
Overall, these data demonstrate the analytical power of NGS in
revealing abnormalities of the immune repertoire, and confirm
that the TRB repertoire of WAS patients is characterized by both
reduced diversity and clonotypic expansions.
The frequency of TRBJ genes usage was also analyzed for
both CD4+ and CD8+ lymphocytes of patients and controls,
and results for both total (inner ring) and unique (outer ring)
sequences were plotted using Microsoft donut graphical repre-
sentation (Figure 5A). With this function, clonotypic expansions
manifest as significant differences in the pattern of outer vs. inner
ring. Minor differences were observed in usage of TRBJ segments
between total and unique clones in CD4+ cells from WAS patients.
In contrast, remarkable differences in the distribution of TRBJ
gene usage between unique vs. total sequences were observed for
CD8+ cells from WAS patients W1, W2, W3, and W5 (Figure 5A),
confirming the presence of clonotypic expansions in this popu-
lation. Analysis of the frequency of TRBJ segment usage showed
that WAS patients had decreased usage of TRBJ2-1 (among both
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FIGURE 5 | J segment usage is skewed in theTRB repertoire of CD8+
cells inWAS patients. (A) Donut graphs compare the representative
frequencies of TRBJ segment usage for total (inner ring) and unique (outer
ring) sequences for controls and WAS patients (see also inset key).
(B) Direct comparison of J segment usage between WAS patients and
controls.
FIGURE 6 | Clonal expansion of theTRB repertoire in CD4+ and CD8+
naïve and memory lymphocytes. The degree of clonal expansion for each
patient’s repertoire is displayed by plotting the cumulative percentage of
unique sequences (x ) vs. the cumulative percentage of total sequences (y ) in
controls (left panels) and patients (right panels). A slope of one would indicate
an even distribution of clonotypes. The dotted gray vertical line indicates 90%
of cumulative unique sequences, with sequences to the right of the line
corresponding to the top 10% most abundant clonotypes.
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FIGURE 7 |TRBV gene usage in CD4+ naive and memory lymphocytes
from healthy controls and patients withWAS. The frequency of usage of
individual TRBV genes in unique TRB sequences is displayed for CD4+ naïve
(top panel) or memory (bottom panel) lymphocytes. The blue line indicates the
average frequency of the two control patients, and the error bars indicate the
SD of the frequency of the controls.
CD4+ and CD8+ cells) and an increased usage of TRBJ2-6 among
CD8+ lymphocytes (Figure 5B).
ANALYSIS OF TRB REPERTOIRE IN NAÏVE AND MEMORY T CELLS
REVEALS A VARIABLE PATTERN OF UNEVEN CLONOTYPE SIZE
DISTRIBUTION IN PATIENTS WITH WAS
Analysis of the distribution of cumulative percentages of unique
and total sequences demonstrated a similar pattern for naïve and
memory CD4+ and CD8+ cells from controls, with the top 10%
most abundant unique clones accounting for 35–50% of the total
clones (Figure 6). In contrast, clonotypic expansions were iden-
tified in memory CD4+ cells from patient W6 (where the top
10% unique sequences accounted for more than 75% of total
sequences), and in both naïve and memory CD8+ cells from the
same patient, with the top 10% most abundant unique clono-
types accounting for over 90% of the total sequences (Figure 6).
Uneven distribution of clonotype size (albeit not as pronounced
as for patient W6) was also observed for naïve and memory CD8+
cells from patient W7.
Analysis of the frequency of TRBV segment usage for all unique
sequences revealed a similar pattern in naïve CD4+ lymphocytes
from patients and controls (Figure 7, top panel). However, a
broader distribution was observed in TRBV gene usage among
memory CD4+ cells from patients with WAS (Figure 7, lower
panel), with increased usage of the TRBV30 and reduced usage
of the TRBV7-9 genes as compared to controls. A similar analy-
sis, performed on CD8+ lymphocytes, showed that naïve CD8+
cells from WAS patients had a tendency toward increased usage of
TRBV genes that are rarely utilized in healthy controls (Figure 8,
top panel). A broad distribution of TRBV gene usage was observed
among memory CD8+ cells from patients with WAS (Figure 8,
lower panel). In order to investigate further usage of TRBV genes
in WAS, the TRBV genes were grouped into a D-proximal set
(from TRBV30 to TRBV27 ) and a D-distal set (from TRBV25-1 to
TRBV2-1). Increased usage of D-distal TRBV genes was demon-
strated in CD8+ lymphocytes (and in particular, among memory
CD8+ cells) from patients with WAS vs. controls (p< 0.05; data
not shown). Altogether, these data confirm that abnormalities of
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FIGURE 8 |TRBV gene in CD8+ naive and memory lymphocytes from
healthy controls and patients withWAS. The frequency of usage of
individual TRBV genes in unique TRB sequences is displayed for CD8+ naïve
(top panel) or memory (bottom panel) lymphocytes. The blue line indicates the
average frequency of the two control patients, and the error bars indicate the
SD of the frequency of the controls.
the TRB repertoire in WAS are more often observed in the CD8+
and in memory T cell compartments.
ANALYSIS OF THE IGH REPERTOIRE REVEALS CLONOTYPIC
EXPANSIONS AND SKEWED USAGE OF IGHV AND IGHJ SEGMENTS IN
PERIPHERAL B CELLS FROM PATIENTS WITH WAS
As shown in Figure 9A, there was a trend for the mean frequency of
the top 100 most abundant unique IGH clonotypes to be higher
in patients with WAS than in controls. The uneven distribution
of clonotype size was confirmed when plotting the cumulative
percentage of unique vs. total sequences (Figure 9B). Further-
more, virtual spectratyping of the CDR3 region of IGH transcripts
(CDR-H3) demonstrated deviation from the bell-shaped pattern
for both total and unique IGH transcripts from patient W7, with
presence of a large fraction of clonotypes with longer CDR-H3
length (51 nucleotides) (Figure 9C).
An increased frequency of γ-containing IGH transcripts was
detected within unique and total sequences from patients with
WAS, associated with a trend toward reduced frequency of
µ-containing transcripts (Figure 10A). Overall, µ-containing
transcripts were most predominantly expressed both in controls
and WAS patients. No differences were observed in the frequency
of usage of IGHD genes (Figure 10B). When usage of IGHV fam-
ilies was analyzed, patients with WAS showed decreased usage of
IGHV5 (Figure 10C). Overall, the pattern of IGHV gene usage
by unique and total sequences was similar in patients and con-
trols (Figure 11), indicating a minimal effect from clonotypic
expansions in the B cell repertoire. However, there was a tendency
toward decreased usage of VH3-66, VH5-51, VH3-74, VH3-53,
and VH3-72, whereas VH3-9, VH3-15, VH4-31, VH4-30-2, and
VH4-30-4 tended to be overexpressed in WAS patients com-
pared with controls. One patient (W4) had an increase in VH4-34
expression.
Next, we sought to investigate whether virtual spectratyping
applied to single IGHV genes or families could reveal abnormal-
ities of CDR-H3 length in patients vs. controls. Distribution of
CDR-H3 length for the abundantly used IGHV1-18 revealed devi-
ations from the bell-shaped curve in patients W3, W4, and W7
as compared to controls (Figure 12A). Abnormalities of CDR-
H3 length in patients with WAS were even more obvious for
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FIGURE 9 | Clonal expansion of the IGH repertoire in circulating
CD19+ lymphocytes. (A)The relative frequency of the 100 most
abundant clones is displayed as a proportion of the total sequences in
four healthy controls (C1–C4) and three WAS patients (W3, W4, and W7).
The black line indicates the mean of the sample. (B)The degree of clonal
expansion for each patient’s repertoire is displayed by plotting the
cumulative percentage of unique clones (x ) vs. the cumulative percentage
of total sequences (y ). A slope of one would indicate an even distribution
of clonotypes. The dotted gray vertical line indicates 90% of cumulative
unique sequences, with sequences to the right of the line corresponding
to the top 10% most abundant clonotypes. (C) Distribution of CDR3
nucleotide length frequencies for both total and unique sequences in
individual WAS patients compared to the mean in controls C1 and C2
(shown as a curve).
FIGURE 10 | Usage of IGHV, IGHD, and IGHC families in circulating B cells from controls andWAS patients. Percent usage of V (A), D (B), and constant
(C) segment families in unique IGH clonotypes is shown for both controls (blue dots) and WAS patients (red squares). Bars indicate the mean and SE.
the IGHV5 family (Figure 12B) and for the IGHV3-66 gene
(Figure 12C), which were less frequently used in WAS patients. Of
note, abnormal distribution of CDR-H3 length was documented
also among unique sequences, indicating restricted diversity of B
lymphocytes expressing these genes.
When usage of IGHJ gene families was analyzed for all unique
sequences, an increased usage of IGHJ3 was observed in WAS
patients than in controls (Figure 13). This was also confirmed
when IGHM - and IGHD-containing transcripts were considered,
and a similar trend was observed for IGHA-expressing clonotypes.
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FIGURE 11 | Individual IGHV gene usage in circulating CD19+ cells
fromWAS patients and controls. The frequency of usage of individual
IGHV genes in unique IGH sequences is displayed. Boxes indicate the
high, low, and median values, and error bars indicate the 5th and 95th
percent confidence intervals for controls. WAS patients are identified by
filled symbols.
In contrast, usage of IGHJ5 was reduced within IGHA-expressing
clonotypes from patients with WAS, and a similar trend was
observed also for IGHM - and IGHG-expressing unique sequences
(Figure 13).
Next, we assessed the frequency and distribution of somatic
mutations within CDR1, CDR2, and FR 2 and 3 for the total B
cell population as well as within IGHM - and IGHG-expressing
sequences. Overall, the rate and distribution of somatic muta-
tions were not significantly different in patients and controls
(Figure 14). However, when the analysis was restricted to IGHG-
containing transcripts, there was a trend toward reduced mutation
frequency in the CDR1 and CDR2 regions in WAS patients as
compared to controls.
DISCUSSION
Development of NGS techniques has permitted analysis of the
immune repertoire in healthy status and in various pathologic
conditions to a depth that could not be achieved with previously
available techniques. In the field of primary immunodeficiencies,
NGS analysis of the antigen receptor repertoire has been limited
so far to patients with leaky variants of SCID, in particular RAG
defects (29–31). In this manuscript, we have reported for the first
time on the use of NGS to analyze the T and B cell repertoire in
patients with WAS. It had been initially thought that WAS is char-
acterized by progressive T cell lymphopenia (32). Consistent with
this, Wada et al. had demonstrated skewing of the TRB repertoire
in patients older than 15 years of age, but not in younger patients
(20). In contrast, Park et al. had found that T cell lymphopenia is
common also in young WAS patients, and affects predominantly
the naïve T cell compartment (10). More recently, Braun et al.
have shown that indeed also young patients with WAS often have
a perturbed TCR repertoire profile, with oligoclonal expansions
of Vβ-expressing clonotypes (21). Here, we have confirmed and
extended these observations. In particular, our data indicate that
patients with WAS have a skewed TRB repertoire, with abundance
of clonotypic expansions especially within memory CD4+ cells
and in the entire CD8+ cell compartment. The vast majority of
the patients studied were children, thus confirming that skew-
ing of the TRB repertoire is a characteristic of WAS already early
in life.
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FIGURE 12 | Complementarity determining region 3 length analysis of
IGHV subgroups. CDR3 length analysis was performed on CD19+ cells
expressing IGHV1-18 (A), IGHV5 (B), or IGHV3-66 (C). The mean distribution
of controls (C1 and C2) is displayed as a blue bar. A double bar indicates the
value of the bar has exceeded the axis limit, and the maximum value is
indicated within brackets.
Several mechanisms may account for skewing of the TRB reper-
toire in patients with WAS. Because of the underlying immunod-
eficiency, patients with WAS are prone to recurrent infections,
including chronic viral infections, which are often associated
with expansion of effector memory T lymphocytes and CD8+
CD45RA+ CCR7− TEMRA cells (33). Seven of the eight patients
studied here had a history of recurrent and/or chronic infec-
tions, and their immunological phenotype was characterized by
increased proportion of effector memory and TEMRA lympho-
cytes. Previous studies had demonstrated a higher degree of
clonotypic expansions and reduced diversity of the TRB reper-
toire within memory than naïve T lymphocytes (34), possibly
reflecting selective pressure conferred by antigenic stimuli. How-
ever, while recurrent and chronic infections may contribute to
determine abnormalities of the TRB repertoire in patients with
WAS, additional causal mechanisms must also be invoked.
Reduced, but detectable, WASp expression was demonstrated
in patient W8, who maintained largely preserved TRB repertoire
diversity. The clinical phenotype of this patient was less severe
than in other patients reported in this study. Additional studies are
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FIGURE 13 | Usage of IGHC genes in unique IGH sequences from
WAS patients and controls. Usage of IGHC families is displayed as
the percentage of the total number of unique clonotypes for both
control (blue dots) and WAS patients (red squares). Results are shown
for all isotypes and for individual isotypes. Bars indicate the mean
and SE.
needed to confirm whether partially preserved WASp expression
and function, and less severe clinical phenotype, are also associated
with maintenance of repertoire diversity.
Abnormalities of antigen receptor repertoire diversity and com-
plexity have been demonstrated in various autoimmune diseases.
This may reflect chronic self antigen-mediated stimulation or
reduced plasticity of immune receptor generation in these patients
(35, 36). However, it should be noted that none of the patients
included in this study had clinically significant autoimmune
disease.
Restoration of WASp expression by somatic reversion has been
associated with partial or full rescue of TCR-mediated signaling
(37), and may therefore, lead to emergence of clonotypic expan-
sion of WASp-expressing cells. In this study, all three patients with
somatic reversion showed uneven distribution of TRB clonotypes
within T cell subsets in which somatic reversion was demonstrated
(CD8+ lymphocytes from patients W1, W3, and W6; CD4+ lym-
phocytes in patient W6). On the other hand, a previous study
demonstrated that revertant WASp-expressing cells from a single
patient showed broader TRB repertoire diversity than WASp-cells
from the same patient (37). The apparent contradiction between
this observation and our data may be reconciled if reduced TCR
signaling in WASp− cells leads to impaired cell survival, and
progressive reduction of repertoire diversity.
Indeed, our data clearly suggest that skewing of TRB repertoire
diversity in WAS is not solely due to factors (chronic infections
and somatic reversion) that sustain clonotypic expansions. In par-
ticular, use of NGS allows analysis of repertoire diversity and
complexity also at the level of unique clonotypes. In normal
individuals, generation of a broad spectrum of antigen receptor
specificities translates into a polyclonal repertoire of expressed
unique sequences, with a bell-shaped pattern of the distribution
of CDR3 lengths demonstrated by virtual spectratyping. In con-
trast, we have observed increased usage of otherwise rarely utilized
TRBV genes (and D-distal genes in particular), and abnormal dis-
tribution of CDR-B3 length among unique clonotypes expressed
by CD8+ lymphocytes from patient with WAS. These data indicate
for the first time that generation and/or maintenance of a diver-
sified repertoire of CD8+ cells is compromised in patients with
WAS. Impairment of thymic output in patients with WAS had been
previously postulated (10); however, the possibility that reduced
survival of peripheral CD8+ cells may also lead to progressive
reduction of repertoire diversity cannot be excluded. Longitudi-
nal studies, performed on uninfected patients identified at birth
because of positive family history or of bleeding episodes associ-
ated with thrombocytopenia, may help dissect the role of impaired
thymic output vs. reduced peripheral cell survival in determining
skewing of the TRB repertoire.
Abnormalities of the B cell compartment in WAS include B
cell lymphopenia, reduced number of CD21/CD35-expressing B
cells and of unswitched and switched CD27+ memory B cells, and
an increased proportion of circulating CD19+ CD21low CD38low
autoreactive-prone B cells (16, 17, 38). Moreover, WASp-deficient
B cells have increased signaling through the BCR and via toll-like
receptors (13, 14), and this may trigger production of autoantibod-
ies. Limited information is available on B cell repertoire diversity
in patients with WAS. Two groups have recently reported skewed
usage of IGHV genes and reduced rate of SHM in circulating B
cells from patients with WAS (16, 17). However, only VH3 and
VH4-expressing clonotypes were included in these studies, and
the method (cloning and sequencing) used allowed only for a lim-
ited number of sequences to be analyzed. By using NGS, we have
confirmed skewing of the B cell IGH repertoire in three patients
with WAS with presence of clonotypic expansions. Moreover, one
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FIGURE 14 | Analysis of somatic hypermutation. The rate (per 1,000
nucleotides) of somatic hypermutation in complementarity determining
regions (CDR) and framework regions (FR) is shown for controls and WAS
patients. Bars indicate the mean±SD.
of the three patients tested (W7) had an aberrant distribution
of CDR-H3 length. Although usage of IGHV genes was rela-
tively preserved, we have detected decreased usage of VH3-66
within total sequences compared with controls. Castiello et al. have
recently reported increased usage of VH3-30 and VH4-34 genes in
WAS patients compared with controls (16), and increased usage
of VH4-34, among both Cµ-expressing transitional B cells and
CD21lo CD38lo B cells has been also reported (17). The VH4-34
gene encodes for self-reactive cold agglutinin antibodies (39, 40),
whereas VH3-30 is highly represented among anti-platelet anti-
bodies (41, 42). In this study, WAS patients and controls did not
differ for the frequency of VH3-30 usage, and increased usage of
VH4-34 was detected in one patient only (W4). However, none of
the patients included in this study had clinical evidence of autoim-
munity, and this may explain the lack of increased usage of IGHV
genes associated with autoimmunity.
Although usage of IGHV genes was not significantly different
in WAS patients vs. controls, virtual spectratyping demonstrated
important abnormalities of CDR-H3 length distribution in WAS
patients vs. controls. Of note, such abnormalities were also docu-
mented when analyzing CDR-H3 length of unique IGH expressed
sequences. Castiello et al. have recently demonstrated increased
release of bone marrow transitional B cells in WAS, secondary to
decreased signaling through CXCL12 (16). Accelerated release of
transitional B cells, whose repertoire is enriched for self-reactive
specificities, may contribute to skewing of distribution of CDR-H3
length among expressed unique IGH clonotypes. However, the
extent of such skewing is such that it is likely that reduced periph-
eral B cell survival may also play a role, similar to what discussed
for T cells above.
WAS patients have increased serum levels of IgG, IgD, and
IgE, and their IgM serum levels are often low (43). Consistent
with this, we found the WAS IGH repertoire to have lower fre-
quency of IGHM -containing sequences and increased frequency
of IGHD and IGHG-expressing sequences, the lattermost being
statistically significant. Despite all of our patients having elevated
peripheral IgE levels and a history of eczema, the frequency of
IGHE-expressing sequences was not different than in controls.
This may reflect the observation that with the exception of patients
W3 and W6, all other patients had only modest elevation of
serum IgE. It is also possible that IGHE-expressing B cells are
predominantly residing in tissues rather than in peripheral blood.
Finally, it is important to keep in mind that IgE molecules account
for a striking minority of all serum immunoglobulin molecules
even in patients with a hyper-IgE phenotype, and larger sample
sizes may be required to detect differences in the frequency of
IGHE-containing transcripts.
Simon et al. have reported reduced rate of SHM among VH3
and VH4-containing IGHG transcripts in sorted memory B cells
from patients with WAS (17). Similarly, Castiello et al. have
observed reduced rate of SHM within the V region of Cγ and
Cα-containing IGH transcripts expressing IGHV3 and IGHV4
families (16). In the present study, the mean mutational rate of
the V region (CDR1-FR3) of Cγ-containing transcripts was lower
in patients with WAS than in controls, but the difference did not
reach statistical significance, also because of the limited sample
size. Finally, we observed a higher mutational rate in CDR than in
FR regions, suggestive of in vivo antigen-driven selection (44).
In summary, by using NGS, we have demonstrated that the
immune repertoire of WAS patients is characterized by clonotypic
expansion and skewing of TRBV gene usage in memory CD4+
and total and memory CD8+ cells as well as skewing of IGHV,
IGHJ, and IGHC usage in peripheral blood B cells. We have also
shown that clonotypic expansions were especially prominent in
patients with chronic infections and/or somatic reversion. More-
over, taking advantage of the analytical power of NGS, we have
demonstrated that abnormalities of CDR-B3 and CDR-H3 length
are also present among unique expressed clonotypes, suggesting
inability to sustain generation or maintenance of a diversified
repertoire. This adds a novel aspect to the complexity of the
immune deficiency of this disease. Additional studies are needed
to define diversity of the antigen receptor repertoire in other
cell subpopulations that have been shown to be affected by the
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disease, such as regulatory T cells, unswitched memory B cells,
and CD21low CD38low B cells. It will also be important to use NGS
to investigate the antigen receptor repertoire in a larger number
of WAS patients, including those with autoimmunity, in order to
assess whether additional abnormalities may be detected. Finally,
along with recently published data (16, 17, 21), this study may pro-
vide a framework to monitor WAS disease correction with HCT
and gene therapy.
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